Our experience of the clinical application of sentinel node biopsy in breast cancer;Nuestra experiencia en la aplicación clínica de la biopsia del ganglio centinela en cáncer de mama

Cirugia Espanola

Volumn 82, Issue 6, 2007, Pages 352-357

  Blanco Saiz, Isabel ^a   Moriyón, Carmen ^b   Santamaría, Luzdivina ^b   Carrocera, Amparo ^b   Díaz, Desireé ^b   Lezana, Marian ^b   Álvarez, Raúl ^b   Angulo, Jesús ^b  

^a Clinica de Medicina Nuclear Geminis   (Spain)

^b HOSPITAL DE CABUEÑES   (Spain)

Author keywords

Breast cancer; Clinical application; Sentinel node biopsy

Indexed keywords

EID: 37149051927     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(07)71746-3     Document Type: Article

References (47)

1. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gammaprobe. Surg Oncol. 1993;2:335-40.
2. Hansen NM, Grube BJ, Giuliano AE. The time has come to change the algorithm for surgical management of early breast cancer. Arch Surg. 2002;137:1131-5.
3. Krag DN, Harlow S. Current status of sentinel node surgery in breast cancer. Oncology. 2003;17:1663-6.
4. Nieweg OE, Van Rijk MC, Valdés Olmos RA, Hoefnagel CA. Sentinel node biopsy and selective lymph node clearance - impact on regional control and survival in breast cancer and melanoma. Eur J Nucl Med Mol Imaging. 2005;32:631-4.
5. Blanco I, Moriyón C, Gómez R, Díez MA, Platero D, Pelletán J, et al. Localización del ganglio centinela en cáncer de mama. Inyección periareolar del radiocoloide. Rev Esp Med Nucl. 2004;23:96-102.
6. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-53.
7. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7:983-90.
8. Vijayakumar V, Boerner PS, Jani AB, Vijayakumar S. A critical review of variables affecting the accuracy and false-negative rate of sentinel node biopsy procedures in early breast cancer. Nucl Med Commun. 2005;26:395-405.
9. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med. 2005;35:116-28.
10. Piñero A, Giménez J, Merck B, Vázquez C, Grupo de Expertos. Reunión de consenso sobre la biopsia selectiva del ganglio centinela en el cáncer de mama. Sociedad Española de Senología y Patología Mamaria. Rev Senología Patolog Mama. 2007;20:16-20.
11. Mateos JJ, Vidal-Sicart S, Zanón G, Pahisa J, Fuster D, Martín F, et al. Sentinel lymph node biopsy in breast cancer patients: subdermal versus peritumoral radiocolloid injection. Nucl Med Commun. 2001;22:17-24.
12. Shen P, Glass EC, DiFronzo LA, Giuliano AE. Dermal versus intra-parenchymal lymphoscintigraphy of the breast. Ann Surg Oncol. 2001;8:241-8.
13. Ortega M, Vidal-Sicart S, Zanón G, Pahisa J, Santamaría G, Velasco M, et al. Estudio comparativo de las diferentes vías de administración del radiotrazador para la localización del ganglio centinela en el cáncer de mama. Rev Esp Med Nucl. 2004;23:153-61.
14. Shimazu K, Tamaki Y, Taguchi T, Takamura Y, Noguchi S. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery. 2002;131:277-86.
15. Povoski SP, Olsen JO, Young DC, Clarke J, Burak WE, Walker MJ, et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol. 2006; 13:1412-21.
16. Piñero-Madrona A, Nicolás-Ruiz F, Galindo-Fernandez PJ, Illana-Moreno J, Canteras-Jordana M, Parrilla-Paricio P. Aspectos técnicos de interés en la localización de drenajes linfáticos en la biopsia del ganglio centinela del cáncer de mama. Cir Esp. 2007;81:264-8.
17. Rodier JF, Velten M, Wilt M, Martel P, Ferron G, Vaini-Elies V, et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol. 2007 [en prensa].
18. Leidenius MH, Leppänen EA, Krogerus LA, Smitten KA. The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer. Nucl Med Commun. 2004;25:233-8.
19. Carcoforo P, Sortini D, Feggi L, Feo CV Soliani G, Panareo S, et al. Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: A single-center study with long-term follow-up. Ann Surg Oncol. 2006; 13:1338-43.
20. Luini A, Galimberti V, Gatti G, Arnone P, Vento AR, Trifiro G, et al. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat. 2005;89:159-63.
21. Fernández A, Cortés M, Benito E, Azpeitia D, Prieto L, Moreno A, et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun. 2001;22:361-6.
22. Van Rijk MC, Nieweg OE, Rutgers EJ, Oldenburg HS, Valdés Olmos R, Hoefnagel CA, et al. Sentinel node biopsy before neoadyuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol. 2006;13:475-9.
23. Fraile M, Mariscal A, Lorenzo C, Solá M, Julián FJ, Gubern JM, et al. Radiolocalización de lesiones mamarias no palpables combinada con la biopsia del ganglio centinela en mujeres con cáncer de mama. Cir Esp. 2005;77:36-9.
24. Zavagno G, Carcoforo P, Franchini Z, Renier M, Barutta L, De Salvo GL, et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol. 2005;31:715-20.
25. Valdés Olmos RA, Tanis PJ, Hoefnagel CA, Nieweg OE, Muller SH, Rutgers EJ, et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun. 2001;22:579-86.
26. Leikola JP, Leppanen EA, Von Smitten KA, Leidenius MH. A second radioisotope enhances intraoperative sentinel node identification in breast cancer patients without visualized nodes on preoperative lymphoscintigraphy. Acta Radiol. 2006;47:760-3.
27. Sanli Y, Berberoglu K, Turkmen C, Ozmen V, Muslumanoglu M, Igci A, et al. The value of combined peritumoral and subdermal injection techniques for lymphoscintigarphy in detection of sentinel lymph node in breast cancer. Clin Nucl Med. 2006;31:690-3.
28. Chakera AH, Friis E, Hesse U, Al-Suliman N, Zerahn B, Hesse B. Factors of importance for scintigraphaphic non-visualization of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging. 2005;32:286-93.
29. Blanco I, Moriyón C. ¿Es siempre necesaria la biopsia de los ganglios centinelas en la cadena mamaria interna en el cáncer de mama? Rev Senología Patolog Mama. 2007;20:35-6.
30. Rousseau C, Classe JM, Campion L, et al. The impact of nonvisualization of sentinel nodes on lymphoscintigraphy in breast cancer. Ann Surg Oncol. 2005;12:1-6.
31. Sanjuán A, Vidal-Sicart S, Zanón G, Pahisa J, Velasco M, Fernández PL, et al. Clinical axillary recurrence after sentinel node biopsy in breast cancer: a follow-up study of 220 patients. Eur J Nucl Med Mol Imaging. 2005;32:932-6.
32. Van Rijk MC, Tanis PJ, Nieweg OE, Valdés Olmos RA, Rutgers EJ, Hoefnagel CA, et al. Clinical implications of sentinel nodes outside the axilla and mammary chain in patients with breast cancer. J Surg Oncol. 2006;94:281-6.
33. Jeruss JS, Winchester DJ, Sener SF, Brinkmann EM, Bilimoria MM, Barrera E, et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol. 2005;12:34-40.
34. Veronesi U, Galimberti V, Mariani L, Gatti G, Paganelli G, Viale G, et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer. 2005;41:231-7.
35. Den Bakker MA, Van Weeszenberg A, De Kanter AY, Beverdam FH, Pritchard C, Van der Kwast TH, et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol. 2002;55:932-5.
36. Nieweg OE, Rutgers EJ, Jansen L, Valdes Olmos RA, Peterse JL, Hoefnagel KA, et al. Is lymphatic mapping in breast cancer adequate and safe? World J Surg. 2001;25:780-8.
37. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy of breast cancer is comparable with that of axillary lymph node dissection. A follow-up study of 4008 procedures. Ann Surg. 2004;240:462-8.
38. Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg. 2003; 138: 52-6.
39. Langer I, Marti WR, Guller U, Moch H, Harder F, Oertli D, et al. A. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases. Ann Surg. 2005;241:152-8.
40. Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel node. Ann Surg. 2005;241:319-25.
41. Carcoforo P, Maestroni U, Querzoli P, Lanzara S, Maravegias K, Feggi L, et al. Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases. World J Surg. 2006;30:1653-7.
42. Bolster MJ, Peer PG, Bult P, Thunnissen FB, Schapers RF, Meijer JW, et al. Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol. 2007;14:181-9.
43. Swenson KK, Mahipal A, Nissen MJ, Tuttle TM, Heaton K, Rally RM. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer. 2005;104:1834-9.
44. Smidt ML, Janssen CM, Kuster DM, Bruggink ED, Strobbe LJ. Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol. 2005;12:29-33.
45. Veronesi U, Galimberti V, Zurrida S, Pigatto F, Veronesi P, Robertson C, et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer. 2001;37:454-8.
46. Culell P, Solernou Ll, Fraile M, Tarazona J, Miguel A, Villa V. Técnica del ganglio centinela en la cirugía del cáncer de mama en un hospital sin servicio de medicina nuclear. Cir Esp. 2007;81:126-9.
47. Segura M, Juncá V, Solsona J, Piqueras A, Puig S, Jimeno J, et al. Impacto de la disponibilidad de un servicio externo de medicina nuclear en la aplicación de la biopsia del ganglio centinela en cirugía del cáncer de mama. Cir Esp. 2006;80:96-100.